Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy

Hideto Yamada, Tomomitsu Tahara, Hisakazu Shiroeda, Ranji Hayashi, Takashi Saito, Masakatsu Nakamura, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Tomoyuki Shibata, Tomiyasu Arisawa

研究成果: Article

6 引用 (Scopus)

抄録

Background&Aim: Histamine plays important physiological roles in upper gastrointestinal tract and acts via the H2 receptor. A polymorphism -1018 G>A (rs2067474) was identified in an enhancer element of the HRH2 promoter. We attempted to clarify the associations of this polymorphism with the progression of gastric mucosal atrophy. methods: Gastric mucosa samples were obtained from 398 subjects with no malignancies. The rs2067474 genotype was determined by PCR-SSCP method. The degree of gastritis was assessed in 366 subjects and serum pepsinogen (PG) I/II levels were measured in 108 subjects. The subjects with atrophy score ≥2 and metaplasia score ≥1 were classified into the severe atrophic gastritis group (SA group). Results: The -1018G>A minor allele frequencies in SA and non-SA groups were 8.02% and 13.3%, respectively (p=0.057). The -1018 GG homozygote had a significantly high risk for gastric mucosal atrophy (OR: 2.03, 95%CI: 1.03-4.01, p=0.042). In H. pylori positive subjects, GG homozygote was a more significant risk factor for gastric mucosal atrophy (OR: 2.32, 95%CI: 1.12-4.81, p=0.023). In addition, in the subjects older than 60 years, GG homozygote had also a significant risk for gastric mucosal atrophy (OR: 2.63, 95%CI: 1.15-6.00, p=0.022). In -1018 GG homozygote, PG I/II ratio was significantly lower in H. pylori positive than negative subjects and was significantly decreased with age (p=0.0032 by ANOVA), whereas it was not in the A carrier. Conclusions: Our results suggest that HRH2 -1018 GG homozygote is a risk factor for the severity of gastric mucosal atrophy under the influence of H. pylori infection, especially in older subjects.

元の言語English
ページ(範囲)139-143
ページ数5
ジャーナルJournal of Gastrointestinal and Liver Diseases
21
発行部数2
出版物ステータスPublished - 01-06-2012

Fingerprint

Homozygote
Atrophy
Stomach
Pylorus
Pepsinogen C
Pepsinogen A
Atrophic Gastritis
Single-Stranded Conformational Polymorphism
Histamine H2 Receptors
Upper Gastrointestinal Tract
Metaplasia
Gastritis
Gastric Mucosa
Gene Frequency
Histamine
Analysis of Variance
Genotype
Polymerase Chain Reaction
Infection
Serum

All Science Journal Classification (ASJC) codes

  • Gastroenterology

これを引用

Yamada, H., Tahara, T., Shiroeda, H., Hayashi, R., Saito, T., Nakamura, M., ... Arisawa, T. (2012). Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy. Journal of Gastrointestinal and Liver Diseases, 21(2), 139-143.
Yamada, Hideto ; Tahara, Tomomitsu ; Shiroeda, Hisakazu ; Hayashi, Ranji ; Saito, Takashi ; Nakamura, Masakatsu ; Tsuchishima, Mutsumi ; Tsutsumi, Mikihiro ; Shibata, Tomoyuki ; Arisawa, Tomiyasu. / Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy. :: Journal of Gastrointestinal and Liver Diseases. 2012 ; 巻 21, 番号 2. pp. 139-143.
@article{31b6bbfa627542d699552f405a5bbf10,
title = "Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy",
abstract = "Background&Aim: Histamine plays important physiological roles in upper gastrointestinal tract and acts via the H2 receptor. A polymorphism -1018 G>A (rs2067474) was identified in an enhancer element of the HRH2 promoter. We attempted to clarify the associations of this polymorphism with the progression of gastric mucosal atrophy. methods: Gastric mucosa samples were obtained from 398 subjects with no malignancies. The rs2067474 genotype was determined by PCR-SSCP method. The degree of gastritis was assessed in 366 subjects and serum pepsinogen (PG) I/II levels were measured in 108 subjects. The subjects with atrophy score ≥2 and metaplasia score ≥1 were classified into the severe atrophic gastritis group (SA group). Results: The -1018G>A minor allele frequencies in SA and non-SA groups were 8.02{\%} and 13.3{\%}, respectively (p=0.057). The -1018 GG homozygote had a significantly high risk for gastric mucosal atrophy (OR: 2.03, 95{\%}CI: 1.03-4.01, p=0.042). In H. pylori positive subjects, GG homozygote was a more significant risk factor for gastric mucosal atrophy (OR: 2.32, 95{\%}CI: 1.12-4.81, p=0.023). In addition, in the subjects older than 60 years, GG homozygote had also a significant risk for gastric mucosal atrophy (OR: 2.63, 95{\%}CI: 1.15-6.00, p=0.022). In -1018 GG homozygote, PG I/II ratio was significantly lower in H. pylori positive than negative subjects and was significantly decreased with age (p=0.0032 by ANOVA), whereas it was not in the A carrier. Conclusions: Our results suggest that HRH2 -1018 GG homozygote is a risk factor for the severity of gastric mucosal atrophy under the influence of H. pylori infection, especially in older subjects.",
author = "Hideto Yamada and Tomomitsu Tahara and Hisakazu Shiroeda and Ranji Hayashi and Takashi Saito and Masakatsu Nakamura and Mutsumi Tsuchishima and Mikihiro Tsutsumi and Tomoyuki Shibata and Tomiyasu Arisawa",
year = "2012",
month = "6",
day = "1",
language = "English",
volume = "21",
pages = "139--143",
journal = "Journal of Gastrointestinal and Liver Diseases",
issn = "1841-8724",
publisher = "Romanian Society of Gastroenterology",
number = "2",

}

Yamada, H, Tahara, T, Shiroeda, H, Hayashi, R, Saito, T, Nakamura, M, Tsuchishima, M, Tsutsumi, M, Shibata, T & Arisawa, T 2012, 'Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy', Journal of Gastrointestinal and Liver Diseases, 巻. 21, 番号 2, pp. 139-143.

Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy. / Yamada, Hideto; Tahara, Tomomitsu; Shiroeda, Hisakazu; Hayashi, Ranji; Saito, Takashi; Nakamura, Masakatsu; Tsuchishima, Mutsumi; Tsutsumi, Mikihiro; Shibata, Tomoyuki; Arisawa, Tomiyasu.

:: Journal of Gastrointestinal and Liver Diseases, 巻 21, 番号 2, 01.06.2012, p. 139-143.

研究成果: Article

TY - JOUR

T1 - Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy

AU - Yamada, Hideto

AU - Tahara, Tomomitsu

AU - Shiroeda, Hisakazu

AU - Hayashi, Ranji

AU - Saito, Takashi

AU - Nakamura, Masakatsu

AU - Tsuchishima, Mutsumi

AU - Tsutsumi, Mikihiro

AU - Shibata, Tomoyuki

AU - Arisawa, Tomiyasu

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background&Aim: Histamine plays important physiological roles in upper gastrointestinal tract and acts via the H2 receptor. A polymorphism -1018 G>A (rs2067474) was identified in an enhancer element of the HRH2 promoter. We attempted to clarify the associations of this polymorphism with the progression of gastric mucosal atrophy. methods: Gastric mucosa samples were obtained from 398 subjects with no malignancies. The rs2067474 genotype was determined by PCR-SSCP method. The degree of gastritis was assessed in 366 subjects and serum pepsinogen (PG) I/II levels were measured in 108 subjects. The subjects with atrophy score ≥2 and metaplasia score ≥1 were classified into the severe atrophic gastritis group (SA group). Results: The -1018G>A minor allele frequencies in SA and non-SA groups were 8.02% and 13.3%, respectively (p=0.057). The -1018 GG homozygote had a significantly high risk for gastric mucosal atrophy (OR: 2.03, 95%CI: 1.03-4.01, p=0.042). In H. pylori positive subjects, GG homozygote was a more significant risk factor for gastric mucosal atrophy (OR: 2.32, 95%CI: 1.12-4.81, p=0.023). In addition, in the subjects older than 60 years, GG homozygote had also a significant risk for gastric mucosal atrophy (OR: 2.63, 95%CI: 1.15-6.00, p=0.022). In -1018 GG homozygote, PG I/II ratio was significantly lower in H. pylori positive than negative subjects and was significantly decreased with age (p=0.0032 by ANOVA), whereas it was not in the A carrier. Conclusions: Our results suggest that HRH2 -1018 GG homozygote is a risk factor for the severity of gastric mucosal atrophy under the influence of H. pylori infection, especially in older subjects.

AB - Background&Aim: Histamine plays important physiological roles in upper gastrointestinal tract and acts via the H2 receptor. A polymorphism -1018 G>A (rs2067474) was identified in an enhancer element of the HRH2 promoter. We attempted to clarify the associations of this polymorphism with the progression of gastric mucosal atrophy. methods: Gastric mucosa samples were obtained from 398 subjects with no malignancies. The rs2067474 genotype was determined by PCR-SSCP method. The degree of gastritis was assessed in 366 subjects and serum pepsinogen (PG) I/II levels were measured in 108 subjects. The subjects with atrophy score ≥2 and metaplasia score ≥1 were classified into the severe atrophic gastritis group (SA group). Results: The -1018G>A minor allele frequencies in SA and non-SA groups were 8.02% and 13.3%, respectively (p=0.057). The -1018 GG homozygote had a significantly high risk for gastric mucosal atrophy (OR: 2.03, 95%CI: 1.03-4.01, p=0.042). In H. pylori positive subjects, GG homozygote was a more significant risk factor for gastric mucosal atrophy (OR: 2.32, 95%CI: 1.12-4.81, p=0.023). In addition, in the subjects older than 60 years, GG homozygote had also a significant risk for gastric mucosal atrophy (OR: 2.63, 95%CI: 1.15-6.00, p=0.022). In -1018 GG homozygote, PG I/II ratio was significantly lower in H. pylori positive than negative subjects and was significantly decreased with age (p=0.0032 by ANOVA), whereas it was not in the A carrier. Conclusions: Our results suggest that HRH2 -1018 GG homozygote is a risk factor for the severity of gastric mucosal atrophy under the influence of H. pylori infection, especially in older subjects.

UR - http://www.scopus.com/inward/record.url?scp=84863429765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863429765&partnerID=8YFLogxK

M3 - Article

C2 - 22720301

AN - SCOPUS:84863429765

VL - 21

SP - 139

EP - 143

JO - Journal of Gastrointestinal and Liver Diseases

JF - Journal of Gastrointestinal and Liver Diseases

SN - 1841-8724

IS - 2

ER -